Patents Assigned to XERAGENX LLC
  • Glycemic control using intrinsic factor bound to a vitamin Bconjugate of a glucagon-like peptide-1 receptor agonist
    Patent number: 11771772
    Abstract: The present invention provides compositions and methods for lowering blood glucose. More specifically, the present invention provides compositions comprising a complex comprising IF and B12 conjugated to a peptide comprising a GLP-1 agonist. Advantageously, the composition may be delivered subcutaneously.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: October 3, 2023
    Assignees: Syracuse University, Xeragenx LLC
    Inventors: Robert Doyle, Jonathan D. Bortz, David S. Hermelin
  • Transgenic plants expressing cobalamin binding proteins
    Patent number: 9751918
    Abstract: The present invention relates to the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. The present invention also relates to the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: September 5, 2017
    Assignee: XERAGENX LLC
    Inventors: Lars Erik Berglund, Torben Ellebaek Petersen, Sergey Nikolaevich Fedosov, Ebba Nexo, Niels Bech Laursen, Erik Ostergaard Jensen